ConvaTec, which is rumored to be exploring a sale, said yesterday that it made its interim CEO, former EMEA president Paul Moraviec, to be its new permanent CEO.
Luxembourg-based ConvaTec, which is owned by private equity firms Avista Capital Partners and Nordic Capital, tapped Moraviec to lead its business in Europe, the Middle East and Africa in 2009.
"I look forward to working with the board as the CEO of ConvaTec," Moraviec said in prepared remarks. "I’m very excited about the future for our business and leading the company’s 9,000 employees in serving the patients, doctors and nurses who rely on us to help improve lives around the world."
“We are pleased to confirm Paul’s appointment as the CEO of ConvaTec," added chairman Magnus Lundberg. "Over his 6 years with ConvaTec, Paul has built a successful business in Europe, and the company has performed well during his tenure as interim CEO. We’re confident that, under his leadership, the company is well positioned for the future."
Globus Medical names J&J’s Scavilla CFO
Globus Medical (NYSE:GMED) said it named former Johnson & Johnson (NYSE:JNJ) vision care finance chief Daniel Scavilla to be its new CFO. Scavilla replaces Richard Baron, who announced a surprise resignation last October.
Thoratec’s new international prez is Boston Scientific vet
Thoratec (NSDQ:THOR) said it named the former sales & marketing vice president for Boston Scientific‘s (NYSE:BSX) S-ICD business, Marta Antonucci, to be its new international president.
Orthofix finally finds a finance chief
Orthofix (NSDQ:OFIX) finally found a permanent CFO, after the sudden departure of Mark Heggestad last September, making interim CFO Doug Rice its finance chief.